-
On december 6, 2011, the food and drug administra- tion (FDA) announced that "HCG products marketed as weight loss aids are unproven and illegal."
-
Insomnia is relatively common and experienced around the world. Estimates have identified prevalence rates ranging from 5-50%.
-
Nutrition is a controversial topic, perhaps because with only minimal effort it is possible to find seemingly credible people advocating for totally opposite messages. In the realm of public media, it is even worse.
Despite public confusion, reviewing the evidence relating nutrition to health and disease yields more clarity than most people realize.
-
The toxicity associated with intestinal habitation by Clostridium difficile ranges from asymptomatic colonization to life-threatening infection. In the United States, C. difficile is the most common cause of health care-associated diarrhea.
-
A low-dose sublingual formulation of Zolpidem has been approved by the FDA for the management of middle-of-the-night (MOTN) awakening. Zolpidem, marketed as Ambien, was originally approved in 1992. The new formulation is marketed by Transcept Pharmaceuticals as Intermezzo.
-
The use of ambulatory blood pressure (BP)monitoring as a diagnostic strategy for the diagnosis of hypertension after finding an initial raised BP reading in the doctor's office would reduce misdiagnosis. The additional costs of ambulatory monitoring are counterbalanced by cost savings from better targeted therapy and, therefore, ambulatory monitoring is recommended for most patients before the start of antihypertensive drug therapy.
-
A post-stroke analysis of more than 20,000 patients in 35 countries showed that the lowest risk systolic blood pressure (BP) range is 130-139 mmHg. There is a J-shaped curve of risk with an increase in recurrent stroke among patients with a systolic BP below 120 mmHg and above 140 mmHg.
-
Behavioral therapy works as well as drug treatment for male overactive bladder.
-
The idiopathic inflammatory myopathies are a heterogeneous group of autoimmune syndromes characterized by subacute or chronic muscle weakness and skeletal muscle inflammation. Of the idiopathic inflammatory myopathies, the best recognized subsets are polymyositis, dermatomyositis, inclusion body myositis (IBM), and the newly described autoimmune necrotizing myopathy.
-